{"id":7593,"date":"2017-07-29T05:00:16","date_gmt":"2017-07-29T09:00:16","guid":{"rendered":"https:\/\/medicarereport.org\/?p=7593"},"modified":"2017-07-27T16:07:39","modified_gmt":"2017-07-27T20:07:39","slug":"many-pharma-transparency-policies-are-vague-ambiguous-and-contradictory","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=7593","title":{"rendered":"Many pharma transparency policies are vague, ambiguous, and contradictory"},"content":{"rendered":"<p>(By Ed Silverman for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">A<\/span>fter several years in which drug makers have been pressured to release clinical trial data, a new\u00a0<a href=\"http:\/\/www.bmj.com\/content\/358\/bmj.j3334\" target=\"_blank\" rel=\"noopener noreferrer\">analysis<\/a>\u00a0finds many companies are still doing an incomplete or inconsistent job of being transparent. <a href=\"https:\/\/www.statnews.com\/pharmalot\/2017\/07\/26\/pharma-trial-data-transparency\/?utm_source=STAT+Newsletters&amp;utm_campaign=17a11fe6c0-Pharmalot&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-17a11fe6c0-149624405\">Continue reading article here&#8230;<\/a><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Ed Silverman for STAT) After several years in which drug makers have been pressured to release clinical trial data,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-7593","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/7593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7593"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/7593\/revisions"}],"predecessor-version":[{"id":7594,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/7593\/revisions\/7594"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}